Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells

Abstract

Class I human leukocyte antigen molecules are nature’s proteome-scanning chips, presenting thousands of endogenously loaded peptides on the surface of virtually every cell in the body. Cytotoxic T cells survey the class I human leukocyte antigen peptide cargo presented, recognize peptides unique to unhealthy cells and destroy diseased cells. A precise understanding of how class I molecules distinguish diseased cells is positioned to drive immune-based diagnostics, therapies and vaccines. When identifying epitopes unique to unhealthy cells, the most experimentally direct approach is to examine the class I-presented peptides of infected/cancerous cells. Here we discuss the strategies adapted for protein production, protein/peptide purification, peptide separation and for maintaining experimental reproducibility during the direct characterization of class I human leukocyte antigen peptides.

Keywords::

• affinity purification
• cancer
• cell pharm
• class I molecule
• cytotoxic T lymphocyte
• epitope
• human leukocyte antigen
• mass spectrometry
• soluble human leukocyte antigen
• virus infected